An increase in oxidized modified lipoprotein (ox-LDL) in patients with psoriasis induces cell death through inflammation and cholesterol accumulation in lysosomes, promoting IL-23 expression through the inducible lectin-like ox-LDL receptor 1 (LOX-1) [45]. This evidence concerns the gene OLR1 and psoriasis.